Amphotericin B: A commentary on its role as an antifungal agent and as a comparative agent in clinical trials

Clinical Infectious Diseases

Volumn 22, Issue SUPPL. 2, 1996, Pages

  Gallis, Harry A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; SULFONAMIDE;

ANTIFUNGAL ACTIVITY; CANDIDIASIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; HISTOPLASMOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; MYCOSIS; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0030054997     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.supplement_2.s145     Document Type: Conference Paper

References (18)

1. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
2. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy N Engl J Med 1994;330:263-72.
3. Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992;93:489-97.
4. Edwards JE Jr. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995:2289-306.
5. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
6. Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995:2306-11.
7. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995:2311-21.
8. Bullock WE. Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995: 2340-53.
9. Chapman SW. Blastomyces dermatitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2 New York: Churchill Livingstone, 1995:2353-65.
10. Dismukes WE. Management of cryptococcosis. Clin Infect Dis 1993;17(suppl 2):S507-12.
11. Denning DW, Lee JY, Hostetler JS, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97:135-44.
12. Graybill JR. Treatment of coccidioidomycosis. Curr Top Med Mycol 1993;5:151-79.
13. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 1995;98:249-56.
14. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993;95:279-85.
15. Restrepo M. A. Paracoccidioides brasiliensis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995:2386-9.
16. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial. Ann Intern Med 1985;103:861-72.
17. Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985;103:872-9.
18. Schmitt H-J. New methods of delivery of amphotericin B. Clin Infect Dis 1993;17(suppl 2):S501-6.